Shattuck Labs, Inc.
CHIMERIC PROTEIN EXPRESSING T-CELLS

Abstract:

The present invention relates to, inter alia, compositions and methods, including engineered T cells that express chimeric antigen receptors and heterologous chimeric proteins that find use in the treatment of cancer.